Two Renowned U.S. Cardiac Electrophysiology Professionals Join Implicity as Scientific Advisors

Prof. Niraj Varma & Dr. Kevin Campbell will help guide the development of new products as the company expands capabilities and continues to lead innovation in remote monitoring and AI.

Cambridge, Mass., November 1st, 2021 – Implicity, a leader in remote patient monitoring and cardiac data management solutions, announced that renowned U.S. cardiac electrophysiology professionals Prof. Niraj Varma and Dr. Kevin Campbell and have joined the leadership team in the role of Scientific Advisors. The two well-known clinicians will help guide the development of new products, capabilities, and services as the company deploys its innovative platform globally. They will support Implicity’s mission to democratize cardiac remote monitoring and equip US facilities with cutting-edge innovation in remote monitoring for a more effective patient-care.

Prof. Niraj Varma, MD, Ph.D., is a Professor of Medicine and Consultant Electrophysiologist at the Cleveland Clinic who pioneered the use of remote monitoring technology of implantable devices. He led the landmark clinical trials and co-chaired the recommendations for clinical use.  Prof Varma received his doctorate from Oxford University and trained in cardiac clinical electrophysiology at Harvard Medical School. A dedicated researcher, he has received grants from the American Heart Association (AHA), a National Research Service Award, and industry funding for studies of innovative technology. Prof. Niraj Varma is a reviewer for several leading medical journals, including New England Journal of Medicine, Lancet, Circulation, Journal of the American College of Cardiology, Heart Rhythm, PACE and Journal of Cardiovascular Electrophysiology.

Dr. Campbell, MD, FACC, is an internationally recognized Cardiologist who specializes in diagnosing and treating heart rhythm disorders. In addition, he’s the former CEO of PaceMate, a cloud-based software platform for remote cardiac care management. Dr. Campbell completed his training in Cardiology at Duke University Medical Center and has collaborated with some of the world’s most distinguished researchers throughout is career.
The author of two books and contributor to U.S. News & World Report, Fox News Channel and other nationally recognized media outlets, Campbell currently practices cardiology and cardiac electrophysiology in Melbourne, Florida with Health First Medical Group. He is also a Fellow of the American College of Cardiology (ACC) and has held numerous leadership roles with the Heart Rhythm Society (HRS).

“We’re thrilled to welcome these two impressive experts who bring with them a wealth of knowledge and insights that will no doubt add tremendous value as we expand our footprint globally and continue to lead innovation in remote monitoring and artificial intelligence.  Based on their field-based feedback, our development and R&D teams will be able to improve our AI-based technology and our data management solutions to provide the best patient-care options to electrophysiologists and device nurses worldwide.,” said Dr. Arnaud Rosier, CEO & co-founder of Implicity.

About Implicity
Implicity is a digital medtech providing a remote monitoring and research platform used by Independent Diagnostic  Testing Facilities and cardiac electrophysiology centers to deliver high-quality care for  their patients with connected Cardiac Implantable Electronic Devices. On this platform,  Implicity aggregates, normalizes and standardizes data from any implantable cardiac device  across all manufacturers. Furthermore, Implicity carries out R&D on AI-based algorithms aiming  at improving patient care and serving the future of preventive medicine. Implicity has been the  first private company authorized to access the Health Data Hub, one of largest databases of  patients with heart diseases in the world, supporting the development of its AI solutions.  Implicity covers more than 45,000 patients in over 70 medical facilities across Europe and the United States.


Posted on

8 November 2021